Adiponectin levels in a large pooled plaque psoriasis study population
Background: Adiponectin is an adipocyte-secreted protein potentially relevant in the context of cardiometabolic comorbidity of psoriasis patients. Objective: This post-hoc analysis aimed to assess the impact of obesity, metabolic syndrome, psoriasis severity and treatment with secukinumab/etanercept...
Main Authors: | S. Gerdes, A. Pinter, M. Biermann, C. Papavassilis, M. Reinhardt |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-07-01
|
Series: | Journal of Dermatological Treatment |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09546634.2019.1621979 |
Similar Items
-
Circulating adiponectin levels in Indian patients with psoriasis and its relation to metabolic syndrome
by: Shraddha Madanagobalane, et al.
Published: (2014-01-01) -
Adiponectin, Leptin and Resistin in Patients with Psoriasis
by: Sylwia Słuczanowska-Głabowska, et al.
Published: (2023-01-01) -
Characterization of responder groups to secukinumab treatment in moderate to severe plaque psoriasis
by: Andreas Pinter, et al.
Published: (2020-11-01) -
Adiponectin in psoriasis and its comorbidities: a review
by: Bai Ruiyang, et al.
Published: (2021-08-01) -
Psoriasis in obesity: comparison of serum levels of leptin and adiponectin in obese subjects - cases and controls
by: Nádia Couto Bavoso, et al.
Published: (2019-05-01)